Former Gilead R&D chief to lead cancer drug startup in Cambridge
May 23, 2018 at 06:00 AM EDT
The company, Kronos Bio, formally launched on Wednesday with $18 million in seed financing.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|